A phase I pharmacokinetic study of ST1571 [imatinib] in patients with advanced malignancies and varying levels of liver dysfunction
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia; Gastrointestinal stromal tumours; Haematological malignancies; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2005 New trial record.